Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
18 results
D2.19 - Can Drug Provocation Be Avoided in Low-Risk Quinolone Reactions?
D2.17 - Diagnostic profitability of penicilloyl-polylysine and minor determinant mixture in urgent/preferred beta-lactam allergy studies in hospitalized patients from january 2023 to december 2025
D2.20 - Selective Fixed Drug Eruption from Etoricoxib with Safe Celecoxib Use: Role of Patch Testing
D2.21 - The Cyto-LTT: A multiplex cytokine assay to detect and assess the strength of T cell reactivity in drug hypersensitivity
D2.29 - Use and knowledge of Phadiatop Infant and Fx5 in children from a primary care healthcare area
D3.51 - Cardiovascular System Problems in Children Athletes with Allergic Diseases
D3.59 - Occupational Cobalt Contact Dermatitis: Clinical Profile and Work implications
D3.52 - Clinical spectrum and diagnostic challenges of paediatric angioedema without wheals
D3.55 - Hereditary angioedema with normal C1-INH: DAB2IP mutation report
D3.56 - Investigation of Serum Eosinophilic Granule Proteins Levels in Children with Chronic Spontaneous Urticaria
D3.58 - Eosinophilic ascites and extreme hypereosinophilia: differential diagnosis through medical treatment
D3.60 - Allergic reaction in bisoprolol overdose
D3.61 - Acquired Food Allergy After Allogeneic Hematopoietic Stem Cell Transplantation From a Non-Allergic Unrelated Donor
D3.62 - Application of a logistic regression model to predict the risk of allergic reactions in children with salmon sensitization (Sal s 1)
D3.50 - Molecular Characterization of Allergen Sensitization and Clinical Associations in a Romanian Cohort Using ALEX² Multiplex Assay
- D3.545 - Natural Killer and Dendritic Cells Leverage Synergistic Interactions to Enhance Treatment of Non-Small Cell Lung Cancer
- D3.547 - Clinical Outcomes and Safety of Drug Desensitization in Chemotherapy-Induced Hypersensitivity
- D3.548 - Refractory and persistent pruritus in an atopic patient: A red flag for underlying malignancy?
Download the app
The congress at your fingertips
Available on
Download